X-48893757-C-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001395498.1(TIMM17B):c.491G>A(p.Gly164Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000344 in 1,162,605 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395498.1 missense
Scores
Clinical Significance
Conservation
Publications
- Renpenning syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
- hamel cerebro-palato-cardiac syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability, Golabi-Ito-hall typeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability, Porteous typeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked intellectual disability, Sutherland-Haan typeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TIMM17B | NM_001395498.1 | c.491G>A | p.Gly164Asp | missense_variant | Exon 6 of 6 | ENST00000696123.1 | NP_001382427.1 | |
TIMM17B | NM_001167947.2 | c.641G>A | p.Gly214Asp | missense_variant | Exon 8 of 8 | NP_001161419.1 | ||
TIMM17B | NM_001395497.1 | c.641G>A | p.Gly214Asp | missense_variant | Exon 7 of 7 | NP_001382426.1 | ||
TIMM17B | NM_005834.5 | c.491G>A | p.Gly164Asp | missense_variant | Exon 7 of 7 | NP_005825.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000272 AC: 3AN: 110376Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000764 AC: 10AN: 130916 AF XY: 0.0000541 show subpopulations
GnomAD4 exome AF: 0.0000352 AC: 37AN: 1052179Hom.: 0 Cov.: 29 AF XY: 0.0000208 AC XY: 7AN XY: 336961 show subpopulations
GnomAD4 genome AF: 0.0000272 AC: 3AN: 110426Hom.: 0 Cov.: 23 AF XY: 0.0000303 AC XY: 1AN XY: 32982 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.641G>A (p.G214D) alteration is located in exon 8 (coding exon 7) of the TIMM17B gene. This alteration results from a G to A substitution at nucleotide position 641, causing the glycine (G) at amino acid position 214 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at